Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007

被引：114

作者：

Furst, D. E.

Breedveld, F. C.

Kalden, J. R.

Smolen, J. S.

Burmester, G. R.

Sieper, J.

Emery, P.

Keystone, E. C.

Schiff, M. H.

Mease, P.

van Riel, P. L. C. M.

Fleischmann, R.

Weisman, M. H.

Weinblatt, M. E.

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90025 USA

[2] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands

[3] Univ Erlangen Nurnberg, Dept Internal Med 3, Inst Clin Immunol, Erlangen, Germany

[4] Vienna Gen Hosp, Inst Rheumatol, Clin Internal Med 3, Vienna, Austria

[5] Charite Hosp, Dept Rheumatol & Clin Immunol, Berlin, Germany

[6] Univ Leeds, Gen Infirm, Dept Rheumatol, Leeds LS1 3EX, W Yorkshire, England

[7] Mt Sinai Hosp, Dept Rheumatol, Toronto, ON M5G 1X5, Canada

[8] Denver Arthritis Clin, Denver, CO USA

[9] Seattle Rhumatol Assoc, Seattle, WA 98104 USA

[10] Univ Nijmegen, Med Ctr, Nijmegen, Netherlands

[11] Univ Texas, SW Med Ctr, Dallas, TX USA

[12] Cedar Sinai Hosp, Los Angeles, CA USA

[13] Brigham & Womens Hosp, Boston, MA 02115 USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷

关键词：

D O I：

10.1136/ard.2007.081430

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2 / 22

页数：21

共 521 条

[1] CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris [J].

Abrams, JR ;

Lebwohl, MG ;

Guzzo, CA ;

Jegasothy, BV ;

Goldfarb, MT ;

Goffe, BS ;

Menter, A ;

Lowe, NJ ;

Krueger, G ;

Brown, MJ ;

Weiner, RS ;

Birkhofer, MJ ;

Warner, GL ;

Berry, KK ;

Linsley, PS ;

Krueger, JG ;

Ochs, HD ;

Kelley, SL ;

Kang, SW .

JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1243-1252

[2]

Adams AB, 2005, J RHEUMATOL, V32, P1374

[3]

AELIAN JA, 2004, EULAR

[4] Pattern of infliximab utilization in rheumatoid arthritis patients at an academic medical center [J].

Agarwal, SK ;

Maier, AL ;

Chibnik, LB ;

Coblyn, JS ;

Fossel, A ;

Lee, R ;

Fanikos, J ;

Fiumara, K ;

Lowry, C ;

Weinblatt, ME .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (06) :872-878

[5] Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab [J].

Ahmadi-Simab, K ;

Lamprecht, P ;

Nölle, B ;

Ai, M ;

Gross, WL .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (07) :1087-1088

[6] Treatment of refractory temporal arteritis with adalimumab [J].

Ahmed, M. Mubashir ;

Mubashir, Eisha ;

Hayat, Samina ;

Fowler, Marjorie ;

Berney, Seth Mark .

CLINICAL RHEUMATOLOGY, 2007, 26 (08) :1353-1355

[7] Long-term remission from life-threatening hypercoagulable state associated with lupus anticoagulant (LA) following rituximab therapy [J].

Ahn, ER ;

Lander, G ;

Bidot, CJ ;

Jy, W ;

Ahn, YS .

AMERICAN JOURNAL OF HEMATOLOGY, 2005, 78 (02) :127-129

[8]

AHNADI SK, 2006, ANN RHEUM DIS, V65, P1117

[9]

Allanore Y, 2004, CLIN EXP RHEUMATOL, V22, P756

[10] Limited effect of rituximab on thrombocytopaenia and anticardiolipin antibodies in a patient with primary antiphospholipid syndrome [J].

Ames, P. R. J. ;

Tommasino, C. ;

Fossati, G. ;

Scenna, G. ;

Brancaccio, V. ;

Ferrara, F. .

ANNALS OF HEMATOLOGY, 2007, 86 (03) :227-228

← 1 2 3 4 5 6 7 8 9 10 →